Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acrongenomics, Inc.
Acrongenomics’ Business Associate Molecular Vision Ltd Appoints Peter Woodford as Chairman
March 13th, 2009
Acrongenomics, Inc. (OTCBB:AGNM) is pleased to announce that its business associate Molecular Vision Limited, an Imperial College London spin-out company developing quantitative point-of-care (POC) diagnostic devices, has appointed Peter Woodford as Non-Executive Chairman. The appointment serves to strengthen the board as Molecular Vision prepares to commercialise its novel detection technology, focusing on low cost POC diagnostic tests in a miniaturised, easy-to-use, disposable format. Mr Woodford has over 35 years' experience in the diagnostics industry. Most recently he spent 15 years with Roche Diagnostics/Boehringer Mannheim, where he was responsible for all global...
Source: Health Business Week (2009-03-13)
|
